Top Markets
Coin of the day
Cotinga Pharmaceuticals Inc. Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Inc.

COTQF
Kedudukan dalam Saham #42319
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused... Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative treatments for cancer and other medical conditions currently lacking adequate solutions. Its leading therapeutic asset is COTI-2, an oral small molecule formulated to target the p53 tumor suppressor gene. The company is also progressing COTI-219, another oral small molecule compound, specifically engineered to inhibit mutant forms of KRAS without affecting the normal functions of the KRAS gene. In collaboration with St. Vincent's University Hospital, Cotinga is conducting research to evaluate COTI-2 when combined with eribulin for patients suffering from triple-negative metastatic breast cancer. The company, which was previously known as Critical Outcome Technologies Inc., rebranded to Cotinga Pharmaceuticals Inc. in January 2018. Its corporate base is situated in Toronto, Canada.
Harga Saham
$0.0001
Disegerakkan terakhir: 2026-07-02
Modal Pasaran
$2.20K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
CA
Perdagangan Cotinga Pharmaceuticals Inc. (COTQF)

Kategori

Sejarah pecahan saham untuk Cotinga Pharmaceuticals Inc. (COTQF)
Saham Cotinga Pharmaceuticals Inc. (simbol: COTQF) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 12, 2026.
Satu saham COTQF yang dibeli sebelum Aug 12, 2026 kini bersamaan dengan 0 saham COTQF.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR